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Background and aim: The sensitivity and specificity of biomarkers and scoring systems used for predicting fatality
of severe sepsis patients remain unsatisfactory. This study aimed to determine the prognostic value of circulating
plasma DNA levels in severe septic patients presenting at the Emergency Department (ED).
Methods: Sixty-seven consecutive patients with severe sepsis and 33 controls were evaluated. Plasma DNA levels
were estimated by real-time quantitative polymerase chain reaction assay using primers for the human β-
hemoglobin and ND2 gene. The patients’ clinical and laboratory data on admission were analyzed.
Results: The median plasma nuclear and mitochondria DNA levels for severe septic patients on admission were
significantly higher than those of the controls. The mean plasma nuclear DNA level on admission correlated
with lactate concentration (γ= 0.36, p= 0.003) and plasma mitochondrial DNA on admission (γ= 0.708, p< 0.001).
Significant prognostic factors for fatality included mechanical ventilation within the first 24 hours (p= 0.013),
mean sequential organ failure assessment (SOFA) score on admission (p= 0.04), serum lactate (p < 0.001), and both
plasma nuclear and mitochondrial DNA on admission (p< 0.001). Plasma mitochondrial DNA was an independent
predictor of fatality by stepwise logistic regression such that an increase by one ng/mL in level would increase
fatality rate by 0.7%.
Conclusion: Plasma DNA has potential use for predicting outcome in septic patients arriving at the emergency
room. Plasma mitochondrial DNA level on admission is a more powerful predictor than lactate concentration
or SOFA scores on admission.
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reproduction in any medium, provided the orwith mortality rates between 30% and 60% in different
reports [1]. Numerous biomarkers for predicting mor-
bidity and mortality in the critical care setting have been
evaluated, but none have been proven entirely useful.
Plasma DNA can be defined as DNA fragments that
are detectable in extracellular fluid and are of two types:
“free” DNA present in plasma (including DNA packed
into nucleosomes of apoptotic cells) or DNA associated
with circulating lymphocytes (considered a minor com-
ponent) [2]. Circulating plasma DNA has recently
received increasing attention and has been studied in
various acute and chronic disorders. Based on current
evidence, DNA is released into the circulation fromtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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is unclear [3,4]. An increase in plasma DNA concentration
may be due to either increased liberation from cells or
decreased clearance efficiency. Experimental animal studies
have produced evidence suggesting that the liver and
kidneys are the prime candidates for plasma DNA removal
[5]. Rapid active liberation processes whereby DNA is
released into plasma from either cell tissues or leucocytes
are also possible. However, in critically ill conditions,
organs responsible for elimination may be damaged as a
consequence of ongoing systemic inflammation.
The early and high concentrations of plasma β-
globulin DNA observed in various critical conditions,
including trauma, stroke, myocardial infarction and
septic shock, have been proposed as prognostic markers
[6-11]. Apoptosis plays an important role in the patho-
physiologic process of sepsis and circulating DNA has
been detected in the plasma of septic patients [12]. Fur-
thermore, fragmented DNA packed during apoptosis
has been found in patients with severe sepsis [13]. Pre-
liminary data from ICU and bacteremia patients suggest
that admission plasma DNA concentrations may be
higher in non-survivors than in survivors [14,15].
The aim of the present study was to investigate the
prognostic value of circulating plasma DNA levels in
patients with severe sepsis in the ED and intensive
care setting.
Patients and methods
Study population and definition
This prospective study on the time course of plasma
nuclear and mitochondrial DNA levels in severe sepsis
and septic shock patients was conducted over a one-
year period (January to December 2011). Sixty-seven
adult non-traumatic patients at Chang Gung Memorial
Hospital in Kaohsiung, a 2482-bed acute care teaching
hospital that provides both primary and tertiary referral
care, were enrolled. The hospital’s Institutional Review
Committee on Human Research approved the study
protocol and all of the patients provided written
informed consent.
All patients aged >18 years consecutively admitted
from the ED were screened daily for severe sepsis and
septic shock according to specific criteria defined by the
American College of Chest Physicians/Society of Critical
Care Medicine. These criteria were suspected or con-
firmed infection, two or more manifestations of systemic
inflammatory response syndrome, and at least one
sepsis-induced acute organ dysfunction. Patients who
met all three criteria were included [16].
For comparison, 33 age- and sex-matched healthy
volunteers who received annual physical check-up and
without clinical evidence of infection were recruited
as controls.Clinical assessment and treatment
The medical records were prospectively recorded using
pre-existing standardized evaluation forms that included
demographic data, Acute Physiology and Chronic
Health Evaluation (APACHE) II score, and the Sequen-
tial Organ Failure Assessment (SOFA) score, which was
calculated during the first 24 hours of admission to as-
sess the severity of organ dysfunction. Basic laboratory
test, lactate concentration, B-type natriuretic peptide,
and inflammatory markers (i.e., plasma C-reactive pro-
tein and procalcitonin) were taken on ED admission.
Data on the source of infection and use of antibiotics
were recorded.
The course of various organ dysfunctions and support-
ive treatments, including vasoactive and ventilator ther-
apies and renal replacement therapies, were recorded.
Physicians evaluated the association of existing organ
dysfunction and severe sepsis daily. Severe organ dys-
function or organ failure was defined as SOFA score ≥3.
Patients on chronic dialysis treatment on admission and
those with severe chronic liver disease were excluded
from the acute organ dysfunction assessment. It was also
institutional practice to consult an infectious disease
specialist for anti-microbial treatment according to treat-
ment guidelines for different infectious etiologies during
the first 24 hours, and the provision of hydrocortisone
(300 mg/day) therapy for 4 days.
Blood sampling and assessment of plasma nuclear
and mitochondrial DNA
Blood samples were collected on presentation to the ED
(Day 1). Follow-up blood samples studies were obtained
on Days 4 and 7 after admission to the wards or ICU.
Under minimal tourniquet pressure, blood was taken
from the antecubital vein using a sterile 19-gauge needle
syringe in a single attempt while the patients was in a
sitting position for at least 10 min. Peripheral venous
blood (3 ml) was collected into EDTA-containing tubes.
Two milliliters of whole blood was drawn from a periph-
eral vein using a 0.9-mm needle, with the cuff pressure
limited to 40 mm Hg. The other samples were kept
in heparinized tubes (50 IU heparin/ml; Sarstedt,
Numbrecht, Germany). Heparin was chosen as the anti-
coagulant because of its superior results compared to
ethylene-diaminetetra-acetic acid, citrate, and a special
cocktail (132 mM ethylenediaminetetra-acetic acid,
0.7% hydroxychloroquine sulfate, and 20 U heparin/ml)
in experimental conditions. Procedural details were as
described previously [17,18].
To ensure cell-free plasma collection, EDTA-blood
were initially centrifuged for 10 min at 3000 rpm, fol-
lowed by separation into a 1.5 ml clear polypropylene
tube with care not to disturb the buffy coat layer. The
newly separated aliquot was centrifuged for another
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then removed by a Pasteur pipette and placed into a
further clear tube and frozen at −20°C prior to extrac-
tion. DNA was extracted from 200-μl plasma samples
using a QIAamp Blood Kit (Qiagen, Frederick, MD) via
the “blood and body fluid protocol” based on the manu-
facturer’s instructions. The exact amount used was
documented for calculation of DNA concentration.
Plasma DNA was measured with the β-globin and
MT-ND2 genes by real-time quantitative polymerase
chain reaction (RT-PCR) assay (Roche Lightcycler;
Roche, Lewes, UK) based on continuous measurements
of SYBR Green fluorescent dye that could bind to
double-stranded DNA generated during PCR [17,18].
The β-globin gene was present in all nucleated cells of
the body, while the MT-ND2 gene was specific to mito-
chondrial DNA. The β-globin PCR system consisted of
amplification primers β- globin-354F (5′-GTG CAC
CTG ACT CCT GAG GAG A-3′) and β-globin- 455R
(5′-CCT TGA TAC CAA CCT GCC CAG-3′). The 101-
base-pair amplicon was detected using primer sequences
and verified in the Genbank database (accession number
U01317) [6]. The MT-ND2 PCR system consisted of
the amplification primers MT-ND2-156F (5′-CAC AGA
AGC TGC CAT CAA GTA-3′) and MT-ND2-245R (5′-
CCG GAG AGT ATA TTG TTG AAG AG-3′). The 90-
base-pair amplicon was detected using primer sequences
and verified in the Genbank database (accession number
NC012920).
The generation of a plasma DNA standard curve was
accomplished using human genomic DNA. The expres-
sion of quantitative results as kilogenome-equivalents/l
was as described previously [17,18]. One genome-
equivalent was defined as the amount of a particular tar-
get sequence contained in a single diploid human cell.
All tests were performed by a quality-controlled
central laboratory at Chang-Gung Memorial Hospital.
Concentrations of CRP were determined by enzyme
immunoassay with a detection limit of <5 mg/dL (EMIT;
Merck Diagnostica; Zurich, Switzerland), while PCT was
measured using Enzyme-Linked Fluorescent Assay
(VIDAS; bioMerieux; Ponte a Ema, Italy). Serum lactate
levels were measured using a serum-based assay cata-
lyzed by lactate oxidase (Vitros, Ortho Clinical Diagnos-
tics, Rochester, NY).
Statistical analysis
Data were expressed as mean ± SD or median (inter-
quartile range). Univariate analyses were compared using
Student’s t-test while categorical variables were com-
pared using χ2 test or Fisher's exact test, as appropriate.
Multiple comparisons among pairs of means were per-
formed by multiple significant tests with Bonferroni
method. Repeated measures of ANOVA were used tocompare plasma cell-free DNA at three different time
points after severe sepsis. Analysis of covariance
(ANCOVA) was used to compare the groups after con-
trolling for potential confounding variables.
Correlation analysis was used to explore the rela-
tionship among 24-h APACHE II score, SOFA score,
Lactate, C-reactive protein, procalcitonin, creatinine
concentration, and levels of plasma nuclear and mito-
chondrial DNA of severe sepsis patients on admission.
Stepwise logistic regression was used to evaluate the
relationship between significant variables and thera-
peutic outcomes, with adjustments for other potential
confounding factors. Variables with zero cell count in a
2-by-2 table were eliminated from logistic analysis and
only those strongly associated with fatality (p < 0.05)
were included in the final model. Receivers operating
characteristic (ROC) curves were used to estimate an
optimal cut-off value for the use of both DNA nuclear
and mitochondria DNA measurements for predicting
death as well as the sensitivity and specificity of the test
at this level. All statistical analyses were conducted using
the SAS software package, ver. 9.1 (2002, SAS Statistical
Institute, Cary, NC).
Results
Baseline characteristics of the study patients
The baseline characteristics of adult severe sepsis and
septic shock cases (n = 67) and healthy controls (n = 33)
showed no significant differences in underlying disease
(i.e., hypertension, diabetes mellitus, and cardiac disease)
(Table 1). The controls had median plasma nuclear
DNA level of 25 ng/ml (range, 19–41 ng/ml) and
median plasma mitochondria DNA level of 16 ng/ml
(range, 7–23 ng/ml). The median plasma nuclear and
mitochondria DNA levels for severe sepsis patients on
ED admission were significantly higher at 436 ng/ml
(range, 216–1140 ng/ml) and 149 ng/ml (range, 79–
304 ng/ml), respectively (both p < 0.001).
In terms of source of infection and causative patho-
gens in septic patients by positive blood culture, 11.9%
(8/67) had Gram-positive bacteria and 40.3% (27/67)
had Gram-negative bacteria (Table 2). The most com-
mon primary site of infection was the pulmonary system
(40.3%). The baseline characteristics of survivors and
non-survivors in severe sepsis patients revealed that
65.7% (44/67) of patients had septic shock within 24-h
of admission and 35.8% (24/67) had ventilator treatment
within 24-h of admission (Table 3). There were signifi-
cant differences in patients with mechanical ventilation
within the first 24-h (p= 0.013), maximum 24-h SOFA
score on admission (p= 0.04), lactate concentration on
admission (p < 0.001), and plasma nuclear and mito-
chondrial DNA within the first 24-h of admission
(p < 0.001) between survivors and non-survivors.







Age (y) (mean±SD) 66.3± 8.0 64.8± 13.8 0.57
Male (%) 66.7 65.7 1.00
Underlying diseases
Diabetes mellitus (%) 54.5 35.8 0.09
Hypertension (%) 60.6 44.8 0.20








Mean (SD) WBC (×109 /L) 6.8 (2.5) 15.9 (10.7) <0.001
Mean (SD) Platelet (×104 /L) 234.4 (66.4) 158.2 (94.4) <0.001
Mean (SD) Hemoglobin(mg/dL) 13.6 (1.7) 11.9 (2.2) <0.001
Mean (SD) CRP (mg/dL) 1.2 (0.9) 189.6 (124.8) <0.001
Median (IQR) plasma nuclear
DNA (ng/mL)
25 (19,41) 436 (216,1140) <0.001
Median(IQR) plasma
mitochondrial DNA ( ng/mL)
16 (7,23) 149 (79,304) <0.001
Note: SD, standard deviation; IQR, inter-quartile range; †, laboratory data at
presentation in the patients group.
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9–30 days). Furthermore, the mean first 24-h nuclear
and mitochondria DNA concentrations were higher in
patients who received mechanical ventilation in the ED
compared to patients who did not (1603 vs. 715;
p= 0.016 and 380 vs. 183; p= 0.047).Table 2 Source of infection and causative pathogens in
septic patients
Survivors
n = 56 (%)
Non-survivors
n = 11 (%)
Total
n = 67 (%)
Primary site of infection [n (%)]
Respiratory tract infection 20 (30.3) 7 (10.6) 27 (40.2)
Urinary tract infection 12 (18.2) 1 (1.5) 13 (19.4)
Intra-abdominal infection 13 (23.2) 1 (1.5) 14 (20.9)
Soft tissue infection 8 (12.1) 2 (3.0) 10 (14.9)
Unknown origin 3 (4.5) 0 (0) 3 (4.5)
Causative pathogens [n (%)]
Escherichia coli 15 (22.4) 1 (1.5) 16 (23.9)
Klebsiella pneumoniae 4 (6.0) 1 (1.5) 5 (7.5)
Other Gram negative bacilli 5 (7.5) 1 (1.5) 6 (9.0)
Streptococcal species 3 (4.5) 1 (1.5) 4 (6.0)
Staphylococcal species 4 (6.0) 0 (0) 4 (6.0)
Negative culture 25 (44.6) 7 (63.6) 32 (47.8)Time course of plasma nuclear and mitochondrial DNA
levels
Time course of circulating nuclear DNA and mitochon-
drial DNA in severe sepsis patients and control subjects
were presented in Figure 1 and Figure 2, respectively. In
patients with severe sepsis, the mean plasma nuclear
DNA was significantly higher in non-survivors than
in survivors on admission (2855 ± 2292 vs. 675 ± 904,
p < 0.001) and 72-h later (2161 ± 2226 vs. 429 ± 255,
p < 0.001). Mean mitochondrial DNA concentrations
were also higher in non-survivors than in survivors on
admission (723 ± 830 vs. 161 ± 128, p < 0.001) and 72-h
later (406 ± 367 vs. 182 ± 129, p = 0.001). Although
plasma nuclear and mitochondrial DNA levels decreased
after anti-microbial therapy, there were no significant
differences between survivors and non-survivors at three
time periods (Days 1, 4, and 7) (p = 0.302 and p = 0.073).
Correlation between plasma DNA and inflammatory
biomarkers
By correlation analysis, the mean plasma nuclear DNA
level on admission significantly correlated with lactate
concentration (γ= 0.36, p= 0.003) and plasma mitochon-
drial DNA on admission (γ= 0.708, p < 0.001). There was
no significant correlation between plasma nuclear DNA
and C-reactive protein (γ= 0.047, p= 0.705), N-terminal
brain natriuretic peptide (γ= 0.005, p= 0.971), and pro-
calcitonin (γ=−0.104, p= 0.971). There were also no
significant correlations between plasma mitochondrial
DNA and lactate concentration (γ= 0.164, p= 0.185), C-
reactive protein (γ=−0.093, p= 0.457), N-terminal brain
natriuretic peptide (γ= 0.014, p= 0.922), and procalcito-
nin (γ=−0.103, p= 0.432).
Outcome and prognostic factors
Eleven of the 67 (16%) patients died in the hospital, in-
cluding 29 who received concomitant steroid therapy on
admission for sepsis. The case fatality in steroid users
and non-users was 17% (5/29) and 15.8% (6/38), respect-
ively (p= 0.874). Potential prognostic factors of the 67
severe septic patients were listed in Table 3. Statistical
analysis of the clinical manifestations and laboratory
data between survivors and non-survivors revealed that
the following were significant: mechanical ventilation
within the first 24 h (p= 0.013), mean SOFA score on
admission (p= 0.04), serum lactate (p < 0.001), and both
the plasma nuclear (p < 0.001) and mitochondrial DNA
on admission (p < 0.001). Of the variables used in the
logistic regression (i.e., mechanical ventilation within
the first 24 h, mean SOFA score on admission, serum
lactate, and plasma nuclear and mitochondrial DNA on
admission), only plasma mitochondrial DNA level was
independently predictive of fatality, with a 0.7% increase
in fatality rate per 1.0 ng/mL increase in level. The area







p value Adjusted OR
(95% CI)
p value
Age (y) (mean±SD) 69.6±9.7 63.5±14.1 0.09
Male/Female 8/3 36/20 0.68(0.16-2.84) 0.74 - -
Underlying diseases [n (%)]
Diabetes mellitus 5 (8) 19 (28) 0.62 (0.17-2.28) 0.51 - -
Hypertension 5 (8) 25 (37) 0.97 (0.26-3.55) 1.00 - -
Liver diseases/alcoholism 3 (5) 8 (12) 0.44 (0.97-2.04) 0.37 - -
Chronic obstructive pulmonary disease 2 (3) 6 (9) 0.54 (0.09-3.11) 0.61 - -
Stroke 3 (5) 9 (13) 0.51 (0.11-2.30) 0.40 - -
Coronary artery disease 0 (0) 8 (12) 0.81 (0.72-0.92) 0.34 - -
Cancer 4 (6) 10 (15) 0.38 (0.09-1.55) 0.22 - -
Connective tissue disease 0 (0) 1 (2) 0.83 (0.75-0.93) 1.00 - -
Chronic renal disease 0 (0) 3 (5) 0.83 (0.74-0.93) 1.00 - -
Glasgow coma score (mean±SD) 13.1±2.4 12.7±3.7 0.76
Shock within 24 hours [n (%)] 7 (11) 37 (56) 1.18 (0.30-4.54) 1.00 - -
Ventilator treatment within 24 hours [n (%)] 8 (12) 16 (24) 0.15 (0.04-0.64) 0.013 - -
Disease severity index (mean±SD)
Maximum 24-h APACHE II score 20.9±3.8 18.9±6.9 0.36
Charlson Co-morbidity Index score 4.2±2.8 2.9±2.8 0.18
Maximum 24-h SOFA score 7.5±1.8 5.6±2.9 0.04
Laboratory data on admission
Mean (SD) white blood cells (×109 /L) 16.9 (12.6) 15.7 (10.4) 0.72
Mean (SD) Hemoglobin(mg/dL) 12.7 (2.7) 11.8 (2.1) 0.24
Mean (SD) Platelet (×104 /L) 114.0 (55.6) 166.9 (98.3) 0.09
Mean (SD) C-reactive protein (mg/dL) 161.8 (107.0) 195.7 (128.2) 0.42
Mean (SD) Glucose (mg/dL) 251.4 (218.8) 167.5 (94.5) 0.24
Mean (SD) Creatinine (mg/dL) 1.7 (0.6) 2.2 (1.6) 0.36
Mean (SD) Lactate (mmol/L) 62.5 (48.2) 30.2 (13.8) <0.001
Mean (SD) Procalcitonin(mg/dL) 18.1 (16.4) 34.0 (52.9) 0.33
Mean (SD) B-type natriuretic peptide (pg/ml) 776.3 (422.4) 679.5 (523.9) 0.79
Median (IQR) plasma nuclear DNA (ng/mL) 2240 (1040–4760) 400 (210–886) <0.001 0.094 1.0 (0.99-1.0)
Median(IQR) plasma mitochondrial DNA (ng/mL) 520 (218–846) 121 (69–227) <0.001 0.015 0.99 (0.99-0.999)
Abbreviations: SD, standard deviation; IQR, inter-quartile range; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment.
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and nuclear DNA level on admission was 0.883
(p < 0.001, 95% CI, 0.774-0.992) and 0.864 (p < 0.001,
95% CI, 0.773-0.984), respectively (Figure 3). The cut-off
value for both plasma mitochondrial and nuclear DNA
for predicting hospital fatality was 198 ng/ml (91% sensi-
tivity and 72% specificity) and 1012 ng/ml (82% sensitiv-
ity and 82% specificity), respectively.
Discussion
This study assessed serial circulating plasma nuclear and
mitochondrial DNA levels in patients with severe sepsis
and septic shock, and produced four major findings.First, both plasma nuclear and mitochondrial DNA con-
centrations on admission are significantly higher in
severe septic patients than in healthy controls. Second,
both plasma nuclear and mitochondrial DNA concentra-
tions on admission are significantly higher in non-
survivors than in survivors. Third, both plasma nuclear
and mitochondrial DNA levels increase shortly after
severe infection and gradually decrease after antimicro-
bial therapy. Furthermore, there were seven (7/11, 64%)
fatal cases with imminent death within 7 days and their
blood samples on Day 7 were not available. This may
explain why the concentration rates of plasma DNA and
plasma mitochondrial DNA were significant higher on
Figure 1 Levels of circulating nuclear DNA in plasma on
different days in severe sepsis patients and control subjects.
#p< 0.001, severe sepsis patients vs. controls; *p< 0.001, survivors vs.
non-survivors.
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decreased in 7 days after treatment between the survivor
and non-survivor groups. Lastly, significant prognostic
factors for fatality include mechanical ventilation within
the first 24 h, mean sequential organ failure assessment
(SOFA) score on admission, serum lactate, and both
plasma nuclear and mitochondrial DNA levels on admis-
sion, but only plasma mitochondrial DNA level is an
independent predictor of fatality. Its cut-off value is
198 ng/ml (91% sensitivity and 72% specificity) and any
increase of 1.0 ng/mL increases fatality rate by 0.7%.
Plasma mitochondrial DNA level on admission is a more
powerful predictor than lactate concentration or SOFA
scores on admission, which are commonly used in clin-
ical practice.
The present study shows that lactate concentrations
on admission correlate independently with admission
plasma DNA concentration. Both measures show signifi-
cant differences between survivors and non-survivors,Figure 2 Levels of circulating mitochondrial DNA in plasma on
different days in severe sepsis patients and control subjects.
#p< 0.001, severe sepsis patients vs. controls; *p< 0.001, survivors vs.
non-survivors.which may reflect similar mechanisms of septic shock-
induced tissue hypoxia on apoptotic or necrotic cell
death. Although the mechanisms underlying apoptosis
in sepsis remain elusive, imbalance between oxygen
delivery and consumption resulting in anaerobic glycoly-
sis and lactate production are central features of severe
septic infection. This may lead to oxygen deprivation,
endothelial cell damage, and subsequent apoptotic cell
death [19]. Previous studies indicate that circulating
DNA originates from apoptotic and necrotic cells in
cancer patients [4]. Huttunen et al. also showed that cell-
free DNA expresses apoptotic fragmentation in bacteremia
non-survivors [20], although the exact mechanism is not
clear, reflecting the extent of cellular damage.
The present study reveals that circulating plasma
nuclear and mitochondrial DNA concentrations are sig-
nificantly higher in patients with mechanical ventilation
on admission to the ED and in those who die within
6 days, and correlate highly with lactate concentrations.
Thus, plasma nuclear and mitochondrial DNA concen-
trations are also good indicators of clinical severity in
the ED. Rhodes et al. measured plasma nuclear DNA
levels in 52 consecutive severely ill patients with or with-
out severe sepsis or septic shocks who were in various
categories of underlying conditions (i.e., traumatic, surgi-
cal, and non-surgical) and receiving heterogeneous treat-
ments (i.e., surgical procedures, conservative treatment,
or combined surgical and conservative management).
However, only one blood sample was taken from each
patient on admission. The study found that plasma
nuclear DNA was higher in ICU patients than in healthy
controls, and was higher in patients who developed
sepsis or who subsequently died either in the ICU or in
the ward [15].
In contrast, the current study enrolled non-traumatic,
non-surgical severe septic patients at the ED patient.
Both serial plasma nuclear and mitochondrial DNA
levels were examined and demonstrated that both had
potential use for predicting outcome in septic patients at
the ED and plasma mitochondrial DNA level on admis-
sion is a more powerful predictor than lactate concen-
tration or SOFA scores on admission. The discrepancy
between the two studies may be attributed to different
methodologies (e.g. patients on enrollment, heteroge-
neous treatments, and plasma DNA level), follow-up
period (one blood sample vs. serial measurement), and
statistical analysis methods.
Because the changing pattern of time course in plasma
nuclear DNA is similar to that of mitochondrial DNA, both
may originate from the same tissues by similar mechanisms.
However, there is no correlation between plasma DNA
concentrations and the three biochemical markers in this
study used to assess prognosis (i.e., C-reactive protein,
brain natriuretic peptide, and procalcitonin) in the ED.
Figure 3 The receiver operating characteristic (ROC) curve for both plasma mitochondrial and nuclear DNA levels on admission. The
area under the ROC curve is 0.883 and 0.864, respectively.
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DNA are different from those implicated in the release
of these biochemical markers. Several forms of sepsis-
induced host cell death have been described during
infection. The type of death the cell undergoes depends
on the nature of the pathogen, pathogen load, and site of
infection. Pyroptotic, apoptotic, autophagic, or oncotic
cells display a distinct set of morphologic and biochem-
ical characteristics [21]. Consequently, the source of free
plasma DNA is complicated by the co-existence of sev-
eral potential mechanisms of DNA release. Further pro-
spective study is needed to clarify this relationship.Study limitation
Although the present study demonstrates that higher
plasma mitochondrial DNA level on admission is a
powerful biomarker for fatality in severe septic patients,
this study has several limitations. First, plasma nuclear
and mitochondrial DNA levels may be influenced by age
and pre-existing diseases. Second, cellular damage indi-
cated by plasma DNA may occur in different tissues and
by several mechanisms of DNA release due to the het-
erogeneity of pathogens and critical illness of patients.
Third, mechanisms of plasma DNA degradation and
clearance also remain uncertain, particularly the impact
of impaired renal and hepatic function on circulating
DNA levels, which may be very complicated. Lastly, the
choice of therapeutic strategy for sepsis (e.g., use of ster-
oids, dosage and duration of steroids) may be different
for each patient based on the preference of his/her doc-
tor. This may cause potential bias in the statistical anal-
ysis. Large-scale prospective studies are warranted toevaluate the prognostic contribution of plasma DNA on
clinical outcomes.
Conclusion
Plasma DNA level has potential use in predicting the
outcome of septic patients at the emergency room.
Plasma mitochondrial DNA level on admission is a more
powerful predictor than lactate concentration or SOFA
score on admission, both of which are commonly used
for outcome prediction in clinical practice. Cell-free
DNA level in blood circulation is a novel biomarker for
the prognosis of clinical diseases rather than diagnosis.
The method has recently received increasing attention
and its clinical application is expected. Based on the
results, serial plasma DNA seems to meet the major
requirement for outcome prediction in the treatment of
severe sepsis. Plasma DNA assay can be considered a
biomarker that should be added to the panel of conven-
tional inflammatory biomarkers.
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